文献速递冠心病

支架内慢性完全闭塞PCI的长期结局劣于原发CTO

Procedural and Long‐Term Outcomes of Percutaneous Coronary Intervention for In‐Stent Chronic Total Occlusion
RSS 订阅 · Catheterization and Cardiovascular Interventions · 2026-10-14

单中心回顾性分析501例CTO PCI(支架内CTO 82例,原发CTO 419例),支架内CTO手术成功率与原发CTO相似(86.6% vs 79.5%),但中位随访713.5天主要复合终点更高(26.4% vs 12.8%,p=0.003),主要由支架内再狭窄驱动。

要点

  • 支架内CTO手术成功率与原发CTO相当,院内并发症无差异。
  • 支架内CTO远期复合终点(再狭窄、心衰住院、心梗、卒中)显著更高。
  • 支架内再狭窄是复合终点升高的主要驱动因素。

核心结论

  • 支架内CTO PCI虽获与原发CTO相当的手术成功率,但长期结局显著更差,尤其支架内再狭窄复发。

研究设计与样本

  • 单中心回顾性分析2018年1月至2023年12月共501例连续CTO PCI(456例患者),其中支架内CTO 82例(16.4%),原发CTO 419例(83.6%)。

主要发现

  • 支架内CTO组糖尿病(58.5% vs 47.5%,p=0.067)及既往心梗(46.3% vs 27.5%,p=0.001)比例更高。
  • 手术成功率(86.6% vs 79.5%,p=0.136)及院内并发症无显著差异。
  • 中位随访713.5天,支架内CTO组复合终点发生率更高(26.4% vs 12.8%,p=0.003),由支架内再狭窄驱动(20.8% vs 5.2%,p<0.001)。
  • 校正后支架内CTO复合终点风险呈升高趋势(HR 2.03,95%CI 1.00−4.11)。
  • 复合终点独立预测因素包括心衰(HR 2.15,95%CI 1.17−3.94),男性为保护因素(HR 0.49,95%CI 0.26−0.90)。

临床怎么用

  • 支架内CTO患者应重视远期再狭窄监测与心衰等合并症管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Background This study examined procedural success and long-term outcomes of percutaneous coronary intervention (PCI) for in-stent chronic total occlusion (IS-CTO) compared with de novo CTO. While contemporary techniques have improved acute success rates for IS-CTO PCI, data on long-term outcomes remain limited. Aims We aimed to examine procedural success rates for IS-CTO PCI using contemporary techniques, evaluate long-term clinical outcomes with extended follow-up, identify independent predictors of major adverse cardiac events, and compare our findings with recent multicenter registries. Methods We analyzed 501 consecutive CTO PCI procedures in 456 patients at our institution between January 2018 and December 2023. Patients were stratified into IS (n = 82, 16.4%) and de novo CTO (n = 419, 83.6%) groups. The primary endpoint was a composite of in-stent restenosis requiring revascularization, heart failure hospitalization, myocardial infarction, and stroke at median follow-up of 713.5 days. Cox proportional hazards regression identified predictors of adverse events. Results Patients with IS-CTO had a higher prevalence of diabetes (58.5% vs. 47.5%, p = 0.067) and prior myocardial infarction (46.3% vs. 27.5%, p = 0.001). Procedural success was similar (86.6% vs. 79.5%, p = 0.136) with comparable in-hospital complications. However, at median follow-up of 713.5 days, patients with IS-CTO experienced higher rates of the composite endpoint (26.4% vs. 12.8%, p = 0.003), driven by in-stent restenosis (20.8% vs. 5.2%, p < 0.001). After adjustment, IS-CTO showed a trend toward increased risk for composite outcome (HR 2.03, 95% CI 1.00−4.11). Independent predictors of composite outcome included heart failure (HR 2.15, 95% CI 1.17−3.94) and male sex (protective: HR 0.49, 95% CI 0.26−0.90). Conclusions Despite achieving procedural success comparable to de novo CTO, IS-CTO PCI is associated with significantly worse long-term outcomes over extended follow-up, particularly recurrent restenosis. These findings underscore the need for improved therapeutic strategies in this challenging population.

来源:Catheterization and Cardiovascular Interventions,查看原文。版权归原作者所有。

引用

  1. Catheterization and Cardiovascular Interventions:Procedural and Long‐Term Outcomes of Percutaneous Coronary Intervention for In‐Stent Chronic Total Occlusion

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。